MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Treatments

Alemtuzumab

Case Studies Reveal New Alemtuzumab Side-effects

MStranslate
January 26, 2017
Alemtuzumab, Research, Treatments
Research Summary: Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy A recent report in Lancet Neurology has highlighted two case...
dimethyl fumarate

Dimethyl Fumarate Linked to Liver Injury

MStranslate
January 17, 2017
Dimethyl fumarate, Research, Treatments
Research Summary: Liver injury associated with dimethyl fumarate in multiple sclerosis patients Last Friday, members of the Office of Surveillance...
Ocrevus

Ocrelizumab in Primary Progressive MS

MStranslate
January 13, 2017
Ocrelizumab, Research, Treatments
Research Summary: Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis There has been a lot of hype over ocrelizumab as the next...
AHSCT

MS: Many Stories – The AHSCT Experience – Aziz

MStranslate
December 19, 2016
MS: Many Stories, Stem Cells, Treatments
Personal Experiences of Undergoing AHSCT for Multiple Sclerosis Our "MS: Many Stories" series is all about having members of the MStranslate...
AHSCT

MS: Many Stories – The AHSCT Experience – Mark

MStranslate
December 19, 2016
MS: Many Stories, Stem Cells, Treatments
Personal Experiences of Undergoing AHSCT for Multiple Sclerosis Our "MS: Many Stories" series is all about having members of the MStranslate...
Monoclonal Antibodies

Monoclonal Antibodies for MS Treatments

MStranslate
October 20, 2016
Research, Understanding Science
By Brett Drummond What’s in a name? I was recently asked a question:  “Why do all of the new MS drugs end in mab?  Does that mean...
Biotin

High Dose Biotin Therapy in Multiple Sclerosis

MStranslate
May 26, 2016
Biotin, Research, Treatments
3 Comments
At the start of May, we posted an update on clinical trials that were evaluating high dose biotin as a treatment for multiple sclerosis. Undertaken...
AAN

Interview: Dr Rebecca Spain – AAN Meeting 2016

MStranslate
April 21, 2016
AAN, Conferences, Research, Treatments
1 Comment
AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR REBECCA SPAIN – OREGON HEALTH AND SCIENCES UNIVERSITY (OHSU), VA PORTLAND...
Antihistamine

Antihistamine may stimulate myelin repair

MStranslate
April 13, 2016
Clinical Trials, Remyelination, Research, Treatments
1 Comment
A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially...
stem cell

Stem Cell Culture Media Improves EAE

MStranslate
April 11, 2016
Research, Stem Cells, Treatments
Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS

Recent Comments

  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026
  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date

Calendar

October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep    

Archives

Categories

Posts

  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.